Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 53, Issue 9, Pages 2951-2955Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01368-15
Keywords
-
Categories
Funding
- Zoonoses Anticipation and Preparedness Initiative (ZAPI project) [115760]
- IMI
- European Commission
- Deutsche Forschungsgemeinschaft [DR 772/10-1]
Ask authors/readers for more resources
The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) has infected at least 1,082 people, including 439 fatalities. So far, no empirical virus isolation study has been done to elucidate infectious virus secretion or serotype variability. Here, we used 51 respiratory samples from 32 patients with confirmed MERS-CoV infection for virus isolation in Vero B4 and Caco-2 cells. We found Caco-2 cells to significantly enhance isolation success over routinely used Vero cells. Isolation success correlated with viral RNA concentration and time after diagnosis as well as with the amount of IgA antibodies secreted in respiratory samples used for isolation. Results from plaque reduction neutralization assays using a representative range of serum samples and virus isolates suggested that all circulating human MERS-CoV strains represent one single serotype. The choice of prototype strain is not likely to influence the success of candidate MERS-CoV vaccines. However, vaccine formulations should be evaluated for their potential to induce IgA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available